General Information of the Protein
Protein ID
PT00955
Protein Name
DNA-dependent protein kinase catalytic subunit
Secondarily
Protein Name
DNPK1
p460
Gene Name
PRKDC
Secondarily
Gene Name
HYRC
HYRC1
Sequence
MAGSGAGVRCSLLRLQETLSAADRCGAALAGHQLIRGLGQECVLSSSPAVLALQTSLVFSRDFGLLVFVRKSLNSIEFRECREEILKFLCIFLEKMGQKIAPYSVEIKNTCTSVYTKDRAAKCKIPALDLLIKLLQTFRSSRLMDEFKIGELFSKFYGELALKKKIPDTVLEKVYELLGLLGEVHPSEMINNAENLFRAFLGELKTQMTSAVREPKLPVLAGCLKGLSSLLCNFTKSMEEDPQTSREIFNFVLKAIRPQIDLKRYAVPSAGLRLFALHASQFSTCLLDNYVSLFEVLLKWCAHTNVELKKAALSALESFLKQVSNMVAKNAEMHKNKLQYFMEQFYGIIRNVDSNNKELSIAIRGYGLFAGPCKVINAKDVDFMYVELIQRCKQMFLTQTDTGDDRVYQMPSFLQSVASVLLYLDTVPEVYTPVLEHLVVMQIDSFPQYSPKMQLVCCRAIVKVFLALAAKGPVLRNCISTVVHQGLIRICSKPVVLPKGPESESEDHRASGEVRTGKWKVPTYKDYVDLFRHLLSSDQMMDSILADEAFFSVNSSSESLNHLLYDEFVKSVLKIVEKLDLTLEIQTVGEQENGDEAPGVWMIPTSDPAANLHPAKPKDFSAFINLVEFCREILPEKQAEFFEPWVYSFSYELILQSTRLPLISGFYKLLSITVRNAKKIKYFEGVSPKSLKHSPEDPEKYSCFALFVKFGKEVAVKMKQYKDELLASCLTFLLSLPHNIIELDVRAYVPALQMAFKLGLSYTPLAEVGLNALEEWSIYIDRHVMQPYYKDILPCLDGYLKTSALSDETKNNWEVSALSRAAQKGFNKVVLKHLKKTKNLSSNEAISLEEIRIRVVQMLGSLGGQINKNLLTVTSSDEMMKSYVAWDREKRLSFAVPFREMKPVIFLDVFLPRVTELALTASDRQTKVAACELLHSMVMFMLGKATQMPEGGQGAPPMYQLYKRTFPVLLRLACDVDQVTRQLYEPLVMQLIHWFTNNKKFESQDTVALLEAILDGIVDPVDSTLRDFCGRCIREFLKWSIKQITPQQQEKSPVNTKSLFKRLYSLALHPNAFKRLGASLAFNNIYREFREEESLVEQFVFEALVIYMESLALAHADEKSLGTIQQCCDAIDHLCRIIEKKHVSLNKAKKRRLPRGFPPSASLCLLDLVKWLLAHCGRPQTECRHKSIELFYKFVPLLPGNRSPNLWLKDVLKEEGVSFLINTFEGGGCGQPSGILAQPTLLYLRGPFSLQATLCWLDLLLAALECYNTFIGERTVGALQVLGTEAQSSLLKAVAFFLESIAMHDIIAAEKCFGTGAAGNRTSPQEGERYNYSKCTVVVRIMEFTTTLLNTSPEGWKLLKKDLCNTHLMRVLVQTLCEPASIGFNIGDVQVMAHLPDVCVNLMKALKMSPYKDILETHLREKITAQSIEELCAVNLYGPDAQVDRSRLAAVVSACKQLHRAGLLHNILPSQSTDLHHSVGTELLSLVYKGIAPGDERQCLPSLDLSCKQLASGLLELAFAFGGLCERLVSLLLNPAVLSTASLGSSQGSVIHFSHGEYFYSLFSETINTELLKNLDLAVLELMQSSVDNTKMVSAVLNGMLDQSFRERANQKHQGLKLATTILQHWKKCDSWWAKDSPLETKMAVLALLAKILQIDSSVSFNTSHGSFPEVFTTYISLLADTKLDLHLKGQAVTLLPFFTSLTGGSLEELRRVLEQLIVAHFPMQSREFPPGTPRFNNYVDCMKKFLDALELSQSPMLLELMTEVLCREQQHVMEELFQSSFRRIARRGSCVTQVGLLESVYEMFRKDDPRLSFTRQSFVDRSLLTLLWHCSLDALREFFSTIVVDAIDVLKSRFTKLNESTFDTQITKKMGYYKILDVMYSRLPKDDVHAKESKINQVFHGSCITEGNELTKTLIKLCYDAFTENMAGENQLLERRRLYHCAAYNCAISVICCVFNELKFYQGFLFSEKPEKNLLIFENLIDLKRRYNFPVEVEVPMERKKKYIEIRKEAREAANGDSDGPSYMSSLSYLADSTLSEEMSQFDFSTGVQSYSYSSQDPRPATGRFRRREQRDPTVHDDVLELEMDELNRHECMAPLTALVKHMHRSLGPPQGEEDSVPRDLPSWMKFLHGKLGNPIVPLNIRLFLAKLVINTEEVFRPYAKHWLSPLLQLAASENNGGEGIHYMVVEIVATILSWTGLATPTGVPKDEVLANRLLNFLMKHVFHPKRAVFRHNLEIIKTLVECWKDCLSIPYRLIFEKFSGKDPNSKDNSVGIQLLGIVMANDLPPYDPQCGIQSSEYFQALVNNMSFVRYKEVYAAAAEVLGLILRYVMERKNILEESLCELVAKQLKQHQNTMEDKFIVCLNKVTKSFPPLADRFMNAVFFLLPKFHGVLKTLCLEVVLCRVEGMTELYFQLKSKDFVQVMRHRDDERQKVCLDIIYKMMPKLKPVELRELLNPVVEFVSHPSTTCREQMYNILMWIHDNYRDPESETDNDSQEIFKLAKDVLIQGLIDENPGLQLIIRNFWSHETRLPSNTLDRLLALNSLYSPKIEVHFLSLATNFLLEMTSMSPDYPNPMFEHPLSECEFQEYTIDSDWRFRSTVLTPMFVETQASQGTLQTRTQEGSLSARWPVAGQIRATQQQHDFTLTQTADGRSSFDWLTGSSTDPLVDHTSPSSDSLLFAHKRSERLQRAPLKSVGPDFGKKRLGLPGDEVDNKVKGAAGRTDLLRLRRRFMRDQEKLSLMYARKGVAEQKREKEIKSELKMKQDAQVVLYRSYRHGDLPDIQIKHSSLITPLQAVAQRDPIIAKQLFSSLFSGILKEMDKFKTLSEKNNITQKLLQDFNRFLNTTFSFFPPFVSCIQDISCQHAALLSLDPAAVSAGCLASLQQPVGIRLLEEALLRLLPAELPAKRVRGKARLPPDVLRWVELAKLYRSIGEYDVLRGIFTSEIGTKQITQSALLAEARSDYSEAAKQYDEALNKQDWVDGEPTEAEKDFWELASLDCYNHLAEWKSLEYCSTASIDSENPPDLNKIWSEPFYQETYLPYMIRSKLKLLLQGEADQSLLTFIDKAMHGELQKAILELHYSQELSLLYLLQDDVDRAKYYIQNGIQSFMQNYSSIDVLLHQSRLTKLQSVQALTEIQEFISFISKQGNLSSQVPLKRLLNTWTNRYPDAKMDPMNIWDDIITNRCFFLSKIEEKLTPLPEDNSMNVDQDGDPSDRMEVQEQEEDISSLIRSCKFSMKMKMIDSARKQNNFSLAMKLLKELHKESKTRDDWLVSWVQSYCRLSHCRSRSQGCSEQVLTVLKTVSLLDENNVSSYLSKNILAFRDQNILLGTTYRIIANALSSEPACLAEIEEDKARRILELSGSSSEDSEKVIAGLYQRAFQHLSEAVQAAEEEAQPPSWSCGPAAGVIDAYMTLADFCDQQLRKEEENASVIDSAELQAYPALVVEKMLKALKLNSNEARLKFPRLLQIIERYPEETLSLMTKEISSVPCWQFISWISHMVALLDKDQAVAVQHSVEEITDNYPQAIVYPFIISSESYSFKDTSTGHKNKEFVARIKSKLDQGGVIQDFINALDQLSNPELLFKDWSNDVRAELAKTPVNKKNIEKMYERMYAALGDPKAPGLGAFRRKFIQTFGKEFDKHFGKGGSKLLRMKLSDFNDITNMLLLKMNKDSKPPGNLKECSPWMSDFKVEFLRNELEIPGQYDGRGKPLPEYHVRIAGFDERVTVMASLRRPKRIIIRGHDEREHPFLVKGGEDLRQDQRVEQLFQVMNGILAQDSACSQRALQLRTYSVVPMTSRLGLIEWLENTVTLKDLLLNTMSQEEKAAYLSDPRAPPCEYKDWLTKMSGKHDVGAYMLMYKGANRTETVTSFRKRESKVPADLLKRAFVRMSTSPEAFLALRSHFASSHALICISHWILGIGDRHLNNFMVAMETGGVIGIDFGHAFGSATQFLPVPELMPFRLTRQFINLMLPMKETGLMYSIMVHALRAFRSDPGLLTNTMDVFVKEPSFDWKNFEQKMLKKGGSWIQEINVAEKNWYPRQKICYAKRKLAGANPAVITCDELLLGHEKAPAFRDYVAVARGSKDHNIRAQEPESGLSEETQVKCLMDQATDPNILGRTWEGWEPWM
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
Atypical protein kinase group
>
Atypical protein kinase PIKK family
Function
Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234). Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234, PubMed:34352203). Must be bound to DNA to express its catalytic properties (PubMed:11955432). Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C) (PubMed:11955432). Recruited by XRCC5 and XRCC6 to DNA ends and is required to (1) protect and align broken ends of DNA, thereby preventing their degradation, (2) and sequester the DSB for repair by NHEJ (PubMed:15574326, PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234). Act as a scaffold protein to aid the localization of DNA repair proteins to the site of damage (PubMed:15574326, PubMed:11955432, PubMed:12649176, PubMed:14734805). The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step (PubMed:15574326, PubMed:11955432, PubMed:12649176, PubMed:14734805). Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion (By similarity). Also involved in modulation of transcription (PubMed:15574326, PubMed:11955432, PubMed:12649176, PubMed:14734805). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Recognizes the substrate consensus sequence [ST]-Q (PubMed:15574326, PubMed:11955432, PubMed:12649176, PubMed:14734805). Phosphorylates 'Ser-139' of histone variant H2AX, thereby regulating DNA damage response mechanism (PubMed:14627815, PubMed:16046194). Phosphorylates ASF1A, DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, FH, SRF, NHEJ1/XLF, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2 (PubMed:2507541, PubMed:2247066, PubMed:1597196, PubMed:8407951, PubMed:8464713, PubMed:9362500, PubMed:9139719, PubMed:10026262, PubMed:10467406, PubMed:12509254, PubMed:11889123, PubMed:14612514, PubMed:14599745, PubMed:15177042, PubMed:18644470, PubMed:26666690, PubMed:30247612, PubMed:14704337, PubMed:16397295, PubMed:26237645, PubMed:28712728, PubMed:29478807). Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA (PubMed:9679063). Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D (PubMed:9363941). Contributes to the determination of the circadian period length by antagonizing phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein stability, most likely through an indirect mechanism (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Also regulates the cGAS-STING pathway by catalyzing phosphorylation of CGAS, thereby impairing CGAS oligomerization and activation (PubMed:33273464). Also regulates the cGAS-STING pathway by mediating phosphorylation of PARP1 (PubMed:35460603).
    Show/Hide
Uniprot ID
Primary ID:
P78527

Secondarily ID:
P78528
Q13327
Q13337
Q14175
Q59H99
Q7Z611
Q96SE6
Q9UME3
    Show/Hide
Ensembl ID
ENSG00000253729
HGNC ID
HGNC:9413
Subcellular Location
Nucleus
Nucleus
Nucleolus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000068 , A-549
Compound ID Compound Name Compound Formula
CP0579400
7-methyl-2-[(7-methylquinolin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C21H22N6O2
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0577945
7-methyl-2-[(7-methylquinazolin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C20H21N7O2
 1
1
IC50 = 21 nM
   TI
   LI
   LO
   TS
CP0552015
7-methyl-2-[(7-methylcinnolin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C20H21N7O2
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0571788
7-methyl-2-[(7-methylquinoxalin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C20H21N7O2
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0562043
9-cyclohexyl-7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-7,9-dihydro-8H-purin-8-one
   Show/Hide
C19H22N8O
 1
1
IC50 = 25.12 nM
   TI
   LI
   LO
   TS
CP0533756
9-(4-hydroxycyclohexyl)-2-(4-methoxy-2-methylanilino)-7-methylpurin-8-one
   Show/Hide
C20H25N5O3
 1
1
IC50 = 31.62 nM
   TI
   LI
   LO
   TS
CP0571631
7-methyl-2-[(7-methylquinolin-6-yl)amino]-9-[(3S)-1-(oxetan-3-yl)pyrrolidin-3-yl]purin-8-one
   Show/Hide
C23H25N7O2
 1
1
IC50 = 39 nM
   TI
   LI
   LO
   TS
CP0418436
7-methyl-2-[(7-methylimidazo[1,2-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C19H21N7O2
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0422671
9-(4,4-difluorocyclohexyl)-7-methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]purin-8-one
   Show/Hide
C19H20F2N8O
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0574338
9-((1r,4r)-4-hydroxycyclohexyl)-7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-7,9-dihydro-8H-purin-8-one
   Show/Hide
C19H22N8O2
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0528088
9-((1s,4s)-4-hydroxy-4-methylcyclohexyl)-7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-7,9-dihydro-8H-purin-8-one
   Show/Hide
C20H24N8O2
 1
1
IC50 = 63.1 nM
   TI
   LI
   LO
   TS
CP0473312
7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one
   Show/Hide
C18H20N8O2
 1
1
IC50 = 92 nM
   TI
   LI
   LO
   TS
CP0571632
7-methyl-9-(1-methylpiperidin-4-yl)-2-[(7-methylquinoxalin-6-yl)amino]purin-8-one
   Show/Hide
C21H24N8O
 1
1
IC50 = 107 nM
   TI
   LI
   LO
   TS
CP0426118
9-(4-hydroxycyclohexyl)-2-(5-methoxy-2-methylanilino)-7-methylpurin-8-one
   Show/Hide
C20H25N5O3
 1
1
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CP0559875
9-((1r,4r)-4-hydroxy-4-methylcyclohexyl)-7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-7,9-dihydro-8H-purin-8-one
   Show/Hide
C20H24N8O2
 1
1
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CP0552016
9-[(3R,4R)-4-fluoro-1-methylpyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H22FN7O
 1
1
IC50 = 128 nM
   TI
   LI
   LO
   TS
CP0579887
9-[(3S)-1-(2-methoxyethyl)pyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C23H27N7O2
 1
1
IC50 = 129 nM
   TI
   LI
   LO
   TS
CP0571634
9-[(3R,4R)-4-fluoropyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C20H20FN7O
 1
1
IC50 = 134 nM
   TI
   LI
   LO
   TS
CP0579976
9-[(3S)-1-(2-hydroxyethyl)pyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C22H25N7O2
 1
1
IC50 = 142 nM
   TI
   LI
   LO
   TS
CP0559874
CHEMBL4459057
   Show/Hide
C19H23N5O3
 1
1
IC50 = 158.49 nM
   TI
   LI
   LO
   TS
CP0577525
9-[(3R,4S)-4-fluoro-1-methylpyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H22FN7O
 1
1
IC50 = 203 nM
   TI
   LI
   LO
   TS
CP0550188
7-methyl-9-(1-methylpiperidin-4-yl)-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C22H25N7O
 1
1
IC50 = 210 nM
   TI
   LI
   LO
   TS
CP0426117
9-(4-hydroxycyclohexyl)-7-methyl-2-(2-methylanilino)purin-8-one
   Show/Hide
C19H23N5O2
 1
1
IC50 = 251.19 nM
   TI
   LI
   LO
   TS
CP0540877
9-(4-hydroxycyclohexyl)-7-methyl-2-[(7-methylimidazo[1,2-a]pyridin-6-yl)amino]purin-8-one
   Show/Hide
C20H23N7O2
 1
1
IC50 = 251.19 nM
   TI
   LI
   LO
   TS
CP0530066
9-cyclopentyl-2-(4-methoxy-2-methylanilino)-7-methylpurin-8-one
   Show/Hide
C19H23N5O2
 1
1
IC50 = 316.23 nM
   TI
   LI
   LO
   TS
CP0571633
7-methyl-2-[(7-methylquinolin-6-yl)amino]-9-piperidin-4-ylpurin-8-one
   Show/Hide
C21H23N7O
 1
1
IC50 = 335 nM
   TI
   LI
   LO
   TS
CP0579065
7-methyl-9-[(3S)-1-methylpyrrolidin-3-yl]-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H23N7O
 1
1
IC50 = 336 nM
   TI
   LI
   LO
   TS
CP0488066
9-cyclohexyl-2-(4-methoxy-2-methylanilino)-7-methylpurin-8-one
   Show/Hide
C20H25N5O2
 1
1
IC50 = 398.11 nM
   TI
   LI
   LO
   TS
CP0569061
7-methyl-9-[(3R)-1-methylpyrrolidin-3-yl]-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H23N7O
 1
1
IC50 = 608 nM
   TI
   LI
   LO
   TS
CP0579416
9-[(3R,4S)-4-fluoropyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C20H20FN7O
 1
1
IC50 = 1056 nM
   TI
   LI
   LO
   TS
CP0543615
7-methyl-9-(1-methylpiperidin-4-yl)-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]purin-8-one
   Show/Hide
C19H23N9O
 1
1
IC50 = 1164 nM
   TI
   LI
   LO
   TS
CP0566608
9-(4-hydroxycyclohexyl)-2-(4-methoxyanilino)-7-methylpurin-8-one
   Show/Hide
C19H23N5O3
 1
1
IC50 = 1258.93 nM
   TI
   LI
   LO
   TS
CP0418435
CHEMBL4529390
   Show/Hide
C20H23N7O2
 1
1
IC50 = 1995.26 nM
   TI
   LI
   LO
   TS
CP0578239
7-methyl-2-[(7-methylcinnolin-6-yl)amino]-9-(1-methylpiperidin-4-yl)purin-8-one
   Show/Hide
C21H24N8O
 1
1
IC50 = 2088 nM
   TI
   LI
   LO
   TS
CP0540878
CHEMBL4456514
   Show/Hide
C18H21N5O2
 1
1
IC50 = 5011.87 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0552015
7-methyl-2-[(7-methylcinnolin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C20H21N7O2
 1
1 IC50 < 0.1 nM
CP0577945
7-methyl-2-[(7-methylquinazolin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C20H21N7O2
 1
1 IC50 < 0.1 nM
CP0579400
7-methyl-2-[(7-methylquinolin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C21H22N6O2
 1
1 IC50 = 0.12 nM
CP0571788
7-methyl-2-[(7-methylquinoxalin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
   Show/Hide
C20H21N7O2
 1
1 IC50 = 0.13 nM
CP0571631
7-methyl-2-[(7-methylquinolin-6-yl)amino]-9-[(3S)-1-(oxetan-3-yl)pyrrolidin-3-yl]purin-8-one
   Show/Hide
C23H25N7O2
 1
1 IC50 = 0.37 nM
CP0003453
9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one
   Show/Hide
C24H15F3N4O
 1
1 IC50 = 0.5 nM
CP0571634
9-[(3R,4R)-4-fluoropyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C20H20FN7O
 1
1 IC50 = 0.51 nM
CP0473312
7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one
   Show/Hide
C18H20N8O2
 2
1 IC50 = 0.6 nM
2 IC50 = 1.58 nM
CP0552016
9-[(3R,4R)-4-fluoro-1-methylpyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H22FN7O
 1
1 IC50 = 0.64 nM
CP0571632
7-methyl-9-(1-methylpiperidin-4-yl)-2-[(7-methylquinoxalin-6-yl)amino]purin-8-one
   Show/Hide
C21H24N8O
 1
1 IC50 = 0.69 nM
CP0571633
7-methyl-2-[(7-methylquinolin-6-yl)amino]-9-piperidin-4-ylpurin-8-one
   Show/Hide
C21H23N7O
 1
1 IC50 = 0.69 nM
CP0579976
9-[(3S)-1-(2-hydroxyethyl)pyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C22H25N7O2
 1
1 IC50 = 0.75 nM
CP0579065
7-methyl-9-[(3S)-1-methylpyrrolidin-3-yl]-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H23N7O
 1
1 IC50 = 1.4 nM
CP0579416
9-[(3R,4S)-4-fluoropyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C20H20FN7O
 1
1 IC50 = 1.7 nM
CP0579887
9-[(3S)-1-(2-methoxyethyl)pyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C23H27N7O2
 1
1 IC50 = 1.7 nM
CP0334283
8-[1-[2-(4-acetylpiperazin-1-yl)ethoxy]dibenzothiophen-4-yl]-2-morpholin-4-ylchromen-4-one
   Show/Hide
C33H33N3O5S
 1
1 IC50 = 2 nM
CP0569061
7-methyl-9-[(3R)-1-methylpyrrolidin-3-yl]-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H23N7O
 1
1 IC50 = 2.6 nM
CP0577525
9-[(3R,4S)-4-fluoro-1-methylpyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C21H22FN7O
 1
1 IC50 = 2.7 nM
CP0550188
7-methyl-9-(1-methylpiperidin-4-yl)-2-[(7-methylquinolin-6-yl)amino]purin-8-one
   Show/Hide
C22H25N7O
 1
1 IC50 = 2.9 nM
CP0075478
2-(4-ethylpiperazin-1-yl)-N-(4-(2-morpholino-4-oxo-4H-chromen-8-yl)dibenzo[b,d]thiophen-1-yl)acetamide
   Show/Hide
C33H34N4O4S
 1
1 IC50 = 5 nM
CP0055294
2-[4-(2-hydroxyethyl)piperazin-1-yl]-N-[4-(2-morpholin-4-yl-4-oxochromen-8-yl)dibenzothiophen-1-yl]acetamide
   Show/Hide
C33H34N4O5S
 1
1 IC50 = 5 nM
CP0017037
8-(dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one
   Show/Hide
C25H19NO3S
 9
1 IC50 = 10 nM
2 IC50 = 12 nM
3 IC50 = 14 nM
4 IC50 = 20 nM
5 IC50 = 28 nM
6 IC50 = 30 nM
7 IC50 = 40 nM
8 IC50 = 42 nM
9 Ki = 0.65 nM
CP0014710
1-(cyclohexen-1-yl)-8-[5-(difluoromethyl)pyridin-3-yl]-[1,2,4]triazolo[4,3-a]quinoxaline
   Show/Hide
C21H17F2N5
 1
1 IC50 = 10 nM
CP0055664
2-(4-methylpiperazin-1-yl)-N-[4-(2-morpholin-4-yl-4-oxochromen-8-yl)dibenzothiophen-1-yl]acetamide
   Show/Hide
C32H32N4O4S
 1
1 IC50 = 12 nM
CP0014718
1-(cyclohepten-1-yl)-8-[5-(difluoromethyl)pyridin-3-yl]-[1,2,4]triazolo[4,3-a]quinoxaline
   Show/Hide
C22H19F2N5
 1
1 IC50 = 12 nM
CP0543615
7-methyl-9-(1-methylpiperidin-4-yl)-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]purin-8-one
   Show/Hide
C19H23N9O
 1
1 IC50 = 14 nM
CP0578239
7-methyl-2-[(7-methylcinnolin-6-yl)amino]-9-(1-methylpiperidin-4-yl)purin-8-one
   Show/Hide
C21H24N8O
 1
1 IC50 = 15 nM
CP0003520
CHEMBL4860129
   Show/Hide
C22H21F2N5O
 1
1 IC50 = 32 nM
CP0005823
CHEMBL4873263
   Show/Hide
C20H15F2N5O
 1
1 IC50 = 35 nM
CP0013686
CHEMBL4850640
   Show/Hide
C22H21F2N5O
 1
1 IC50 = 39 nM
CP0014320
CHEMBL4871998
   Show/Hide
C21H17F2N5
 1
1 IC50 = 40 nM
CP0014706
8-[5-(difluoromethyl)pyridin-3-yl]-1-(3,6-dihydro-2H-pyran-4-yl)-[1,2,4]triazolo[4,3-a]quinoxaline
   Show/Hide
C20H15F2N5O
 1
1 IC50 = 41 nM
CP0013685
8-[5-(difluoromethyl)pyridin-3-yl]-1-(2,3,6,7-tetrahydrooxepin-4-yl)-[1,2,4]triazolo[4,3-a]quinoxaline
   Show/Hide
C21H17F2N5O
 1
1 IC50 = 81 nM
CP0014701
8-[5-(difluoromethyl)pyridin-3-yl]-1-(oxan-4-yl)-[1,2,4]triazolo[4,3-a]quinoxaline
   Show/Hide
C20H17F2N5O
 1
1 IC50 = 105 nM
CP0089243
2-(4-Chloro-phenyl)-6-morpholin-4-yl-pyran-4-one
   Show/Hide
C15H14ClNO3
 1
1 IC50 = 180 nM
CP0079476
2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one
   Show/Hide
C18H17NO3
 1
1 IC50 = 190 nM
CP0177234
2-(4-Methoxy-phenyl)-6-morpholin-4-yl-pyran-4-one
   Show/Hide
C16H17NO4
 1
1 IC50 = 220 nM
CP0016546
2-(morpholin-4-yl)-benzo[h]chromen-4-one
   Show/Hide
C17H15NO3
 2
1 IC50 = 230 nM
2 IC50 = 300 nM
CP0022970
2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one
   Show/Hide
C16H15N3O2
 1
1 IC50 = 280 nM
CP0171211
2-(4-Methoxy-phenyl)-6-morpholin-4-yl-thiopyran-4-one
   Show/Hide
C16H17NO3S
 1
1 IC50 = 280 nM
CP0002420
2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
   Show/Hide
C19H17NO3
 7
1 IC50 = 300 nM
2 IC50 = 1200 nM
3 IC50 = 1300 nM
4 IC50 = 1400 nM
5 IC50 = 1470 nM
6 IC50 = 1600 nM
7 Ki = 6000 nM
CP0180777
7-fluoro-6-[6-(methoxymethyl)pyridin-3-yl]-4-[[(1S)-1-(1-methylpyrazol-3-yl)ethyl]amino]quinoline-3-carboxamide
   Show/Hide
C23H23FN6O2
 1
1 IC50 = 370 nM
CP0085461
2-Morpholin-4-yl-benzo[g]chromen-4-one
   Show/Hide
C17H15NO3
 1
1 IC50 = 400 nM
CP0185655
2-(4-Chloro-phenyl)-6-morpholin-4-yl-thiopyran-4-one
   Show/Hide
C15H14ClNO2S
 1
1 IC50 = 530 nM
CP0180776
6-[6-(methoxymethyl)pyridin-3-yl]-4-[[(1S)-1-(oxan-4-yl)ethyl]amino]quinoline-3-carboxamide
   Show/Hide
C24H28N4O3
 1
1 IC50 = 643 nM
CP0276703
2-Morpholin-4-yl-6-phenyl-thiopyran-4-one
   Show/Hide
C15H15NO2S
 1
1 IC50 = 720 nM
CP0370455
2-Morpholin-4-yl-6-phenyl-pyran-4-one
   Show/Hide
C15H15NO3
 1
1 IC50 = 1100 nM
CP0089244
6-Methoxy-4-morpholin-4-yl-chromen-2-one
   Show/Hide
C14H15NO4
 2
1 IC50 = 1200 nM
2 IC50 = 1700 nM
CP0057474
(2S,4R)-4-Mercapto-2-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-1-carboxylic acid 2-methoxycarbonyl-phenyl ester
   Show/Hide
C13H13NO3
 3
1 IC50 = 1300 nM
2 IC50 = 4300 nM
3 IC50 > 10000 nM
CP0210624
2-Thiomorpholin-4-yl-benzo[h]chromen-4-one
   Show/Hide
C17H15NO2S
 1
1 IC50 = 1380 nM
CP0332163
8-Methoxy-2-morpholin-4-yl-chromen-4-one
   Show/Hide
C14H15NO4
 1
1 IC50 = 1800 nM
CP0337323
2-(piperidin-1-yl)-4H-benzo[h]chromen-4-one
   Show/Hide
C18H17NO2
 1
1 IC50 = 3810 nM
CP0273485
3-Morpholin-4-yl-benzo[f]chromen-1-one
   Show/Hide
C17H15NO3
 1
1 IC50 = 4000 nM
CP0316257
4-Morpholin-4-yl-chromen-2-one
   Show/Hide
C13H13NO3
 1
1 IC50 = 4800 nM
CP0332164
7-Methoxy-4-morpholin-4-yl-chromen-2-one
   Show/Hide
C14H15NO4
 1
1 IC50 = 5400 nM
CP0020505
(1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-6,11,16-trioxo-13,17-dioxapentacyclo[10.6.1.0^{2,10}.0^{5,9}.0^{15,19}]nonadeca-2(10),12(19),14-trien-3-yl acetate
   Show/Hide
C23H24O8
 1
1 Ki = 120 nM
Clinical Information about the Protein
Target 1 ( DNA-dependent protein kinase catalytic (PRKDC) )
Target Type Clinical trial Target
Disease 2 Target-related Diseases  2
1 Solid tumour/cancer [ICD-11: 2A00-2F9Z]
2 Locally advanced rectal cancer [ICD-11: 2B92]
Clinical Trial Drug(s) 3 Clinical Trial Drugs  3
1 AZD7648 Phase 1/2
Solid tumour/cancer
2 M3814 Phase 1/2
Locally advanced rectal cancer
3 M9831 Phase 1
Solid tumour/cancer
Investigative Drug(s) 1 Investigative Drug  1
1 KU-55933 Investigative
Solid tumour/cancer